{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:12:16Z","timestamp":1784131936285,"version":"3.55.0"},"reference-count":22,"publisher":"Biophysical Society of China","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["swwlxb"],"published-print":{"date-parts":[[2025]]},"DOI":"10.52601\/bpr.2024.240030","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:44:03Z","timestamp":1726202643000},"page":"12","source":"Crossref","is-referenced-by-count":5,"title":["Features of the monocyte inflammatory response in patients with premature coronary artery disease"],"prefix":"10.52601","volume":"11","author":[{"given":"Tatiana","family":"Blokhina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kirichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Markina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulyana","family":"Khovantseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Melnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Guseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Bazanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kozlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"30428","reference":[{"key":"10.52601\/bpr.2024.240030.swwlxb.1","doi-asserted-by":"publisher","unstructured":"Amasyali B, Kose S, Kursaklioglu H, Barcin C, Kilic A (2009) Monocyte chemoattractant protein-1 in acute coronary syndromes: complex vicious interaction. Int J Cardiol 136: 356\u2212357","DOI":"10.1016\/j.ijcard.2008.04.080"},{"key":"10.52601\/bpr.2024.240030.swwlxb.2","doi-asserted-by":"publisher","unstructured":"Bekkering S, Quintin J, Joosten LA, van der Meer JW, Netea MG, Riksen NP (2014) Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler Thromb Vasc Biol 34: 1731\u22121738","DOI":"10.1161\/ATVBAHA.114.303887"},{"key":"10.52601\/bpr.2024.240030.swwlxb.3","doi-asserted-by":"publisher","unstructured":"Crossman D, Rothman A (2017) The canakinumab antiinflammatory thrombosis outcome study trial. J Thorac Dis 9(12): 4922\u22124925","DOI":"10.21037\/jtd.2017.11.96"},{"key":"10.52601\/bpr.2024.240030.swwlxb.4","doi-asserted-by":"publisher","unstructured":"Dash SP, Gupta S, Sarangi PP (2024) Monocytes and macrophages: origin, homing, differentiation, and functionality during inflammation. Heliyon 10(8): e29686. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29686","DOI":"10.1016\/j.heliyon.2024.e29686"},{"key":"10.52601\/bpr.2024.240030.swwlxb.5","doi-asserted-by":"publisher","unstructured":"de Gaetano M, Quacquaruccio G, Di Castelnuovo A, Nowak N, Dorn J, Donati MB, Freudenheim JL, Trevisan M, Iacoviello L (2011) Haplotypes and haplotype-pairs of IL-1 beta and IL-6 genes and risk of non fatal myocardial infarction in the Western New York Acute MI Study. Thromb Haemost 106: 1231\u22121233","DOI":"10.1160\/TH11-06-0377"},{"key":"10.52601\/bpr.2024.240030.swwlxb.6","doi-asserted-by":"publisher","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313\u2212326","DOI":"10.1089\/jir.2008.0027"},{"key":"10.52601\/bpr.2024.240030.swwlxb.7","doi-asserted-by":"publisher","unstructured":"Georgakis MK, de Lemos JA, Ayers C, Wang B, Bj\u00f6rkbacka H, Pana TA, Thorand B, Sun C, Fani L, Malik R, Dupuis J, Engstr\u00f6m G, Orho-Melander M, Melander O, Boekholdt SM, Zierer A, Elhadad MA, Koenig W, Herder C, Hoogeveen RC, Kavousi M, Ballantyne CM, Peters A, Myint PK, Nilsson J, Benjamin EJ, Dichgans M (2021a) Association of circulating monocyte chemoattractant protein-1 levels with cardiovascular mortality: a meta-analysis of population-based studies. JAMA Cardiol 6: 587\u2212592","DOI":"10.1001\/jamacardio.2020.5392"},{"key":"10.52601\/bpr.2024.240030.swwlxb.8","doi-asserted-by":"publisher","unstructured":"Georgakis MK, Gill D, Rannikm\u00e4e K, Traylor M, Anderson CD, Lee JM, Kamatani Y, Hopewell JC, Worrall BB, Bernhagen J, Sudlow CLM, Malik R, Dichgans M (2019a) Genetically determined levels of circulating cytokines and risk of stroke. Circulation 139: 256\u2212268","DOI":"10.1161\/CIRCULATIONAHA.118.035905"},{"key":"10.52601\/bpr.2024.240030.swwlxb.9","doi-asserted-by":"publisher","unstructured":"Georgakis MK, Malik R, Bj\u00f6rkbacka H, Pana TA, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ, Boekholdt SM, Engstr\u00f6m G, Herder C, Hoogeveen RC, Koenig W, Melander O, Orho-Melander M, Schiopu A, S\u00f6derholm M, Wareham N, Ballantyne CM, Peters A, Seshadri S, Myint PK, Nilsson J, de Lemos JA, Dichgans M (2019b) Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17180 individuals. Circ Res 125: 773\u2212782","DOI":"10.1161\/CIRCRESAHA.119.315380"},{"key":"10.52601\/bpr.2024.240030.swwlxb.10","doi-asserted-by":"publisher","unstructured":"Georgakis MK, van der Laan SW, Asare Y, Mekke JM, Haitjema S, Schoneveld AH, de Jager SCA, Nurmohamed NS, Kroon J, Stroes ESG, de Kleijn DPV, de Borst GJ, Maegdefessel L, Soehnlein O, Pasterkamp G, Dichgans M (2021b) Monocyte-chemoattractant protein-1 levels in human atherosclerotic lesions associate with plaque vulnerability. Arterioscler Thromb Vasc Biol 41: 2038\u22122048","DOI":"10.1161\/ATVBAHA.121.316091"},{"key":"10.52601\/bpr.2024.240030.swwlxb.11","doi-asserted-by":"publisher","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F (2022) The role of inflammation in cardiovascular disease. Int J Mol Sci 23: 12906. https:\/\/doi.org\/10.3390\/ijms232112906","DOI":"10.3390\/ijms232112906"},{"key":"10.52601\/bpr.2024.240030.swwlxb.12","doi-asserted-by":"publisher","unstructured":"Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D'Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB; IGIGI Investigators (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation <i>in vitro<\/i>. Arterioscler Thromb Vasc Biol 25: 222\u2212227","DOI":"10.1161\/01.ATV.0000150039.60906.02"},{"key":"10.52601\/bpr.2024.240030.swwlxb.13","doi-asserted-by":"publisher","unstructured":"Kim KW, Ivanov S, Williams JW (2020) Monocyte recruitment, specification, and function in atherosclerosis. Cells 10: 15. https:\/\/doi.org\/10.3390\/cells10010015","DOI":"10.3390\/cells10010015"},{"key":"10.52601\/bpr.2024.240030.swwlxb.14","doi-asserted-by":"crossref","unstructured":"Le A, Peng H, Golinsky D, Di Scipio M, Lali R, Par\u00e9 G (2024) What causes premature coronary artery disease? <i>Curr Atheroscler Rep<\/i> 26(6): 189-203","DOI":"10.1007\/s11883-024-01200-y"},{"key":"10.52601\/bpr.2024.240030.swwlxb.15","doi-asserted-by":"crossref","unstructured":"Libby P, Mallat Z, Weyand C (2021) Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe. Cardiovasc Res 117(13): 2503\u22122505","DOI":"10.1093\/cvr\/cvab332"},{"key":"10.52601\/bpr.2024.240030.swwlxb.16","doi-asserted-by":"crossref","unstructured":"Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA (1986). Inducible interleukin\u20131 gene expression in human vascular smooth muscle cells. <i>J Clin Invest<\/i> 78: 1432\u20131438","DOI":"10.1172\/JCI112732"},{"key":"10.52601\/bpr.2024.240030.swwlxb.17","doi-asserted-by":"publisher","unstructured":"Neeland IJ, Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, Vaccarino V, Zafari AM, Samady H, Quyyumi AA (2012) Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J 164: 547\u2212552","DOI":"10.1016\/j.ahj.2012.07.007"},{"key":"10.52601\/bpr.2024.240030.swwlxb.18","doi-asserted-by":"publisher","unstructured":"Nikiforov NG, Wetzker R, Kubekina MV, Petukhova AV, Kirichenko TV, Orekhov AN (2019) Trained circulating monocytes in atherosclerosis: <i>ex vivo<\/i> model approach. Front Pharmacol 10: 725. https:\/\/doi.org\/10.3389\/fphar.2019.00725","DOI":"10.3389\/fphar.2019.00725"},{"key":"10.52601\/bpr.2024.240030.swwlxb.19","doi-asserted-by":"publisher","unstructured":"Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351: 2599\u22122610","DOI":"10.1056\/NEJMoa040967"},{"key":"10.52601\/bpr.2024.240030.swwlxb.20","doi-asserted-by":"publisher","unstructured":"Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767\u22121772","DOI":"10.1161\/01.CIR.101.15.1767"},{"key":"10.52601\/bpr.2024.240030.swwlxb.21","doi-asserted-by":"publisher","unstructured":"Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P, Brilakis E, Kornman KS, Witztum JL (2014) Pro-inflammatory interleukin-1 genotypes potentiate the risk of CAD and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a). JACC 63: 1724\u22121734","DOI":"10.1016\/j.jacc.2013.12.030"},{"key":"10.52601\/bpr.2024.240030.swwlxb.22","doi-asserted-by":"crossref","unstructured":"Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Fr\u00f8land SS, Semb AG, Aukrust P, Dam\u00e5s JK (2004) Increased expression of interleukin-1 in CAD with downregulatory effects of HMG-CoA reductase inhibitors. <i>Circulation 10<\/i>9: 1966-1972","DOI":"10.1161\/01.CIR.0000125700.33637.B1"}],"container-title":["Biophysics Reports"],"original-title":[],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T05:20:21Z","timestamp":1756099221000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biophysics-reports.org\/article\/doi\/10.52601\/bpr.2024.240030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"alternative-id":["2024-030-MI"],"URL":"https:\/\/doi.org\/10.52601\/bpr.2024.240030","relation":{},"ISSN":["2364-3439","2364-3420"],"issn-type":[{"value":"2364-3439","type":"print"},{"value":"2364-3420","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}